Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-14-064726
Filing Date
2014-11-03
Accepted
2014-11-03 17:04:39
Documents
2
Period of Report
2014-11-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v392997_3.html 3  
1 OWNERSHIP DOCUMENT v392997_3.xml 3 1570
2 EXHIBIT 24.1 v392997_ex24-1.htm EX-24 4592
  Complete submission text file 0001144204-14-064726.txt   7801
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, #455 CARMIEL L3 20100
Business Address
Manor Moshe (Reporting) CIK: 0001623532 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 141190205